Abstract
Extensive submicroscopic deletions adjacent to the breakpoint on derivative chromosome 9 [der(9)] have been reported in a subset of Chronic Myeloyd Leukemia (CML) patients and have been associated with an adverse outcome with conventional drugs and α-interferon (α-IFN). Huntly et al (
Blood.
2003
; 102
.2205
–12Blood.
2005
; 105
:2281
–6Disclosure: No relevant conflicts of interest to declare.
ACKNOWLEDGMENTS: COFIN 2003, FIRB 2001, A.I.R.C., C.N.R., Fondazione del Monte di Bologna e Ravenna, LeukemiaNet founds, A.I.L.
Author notes
*
Corresponding author
2006, The American Society of Hematology
2006
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal